APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Intestinal Medicine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pet Intestinal Medicine Market Outlook and Growth Opportunities 2026

21 December 2025194 pages

Choose your research edition.

Industry ResearchPet Intestinal Medicine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Intestinal Medicine Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Pet Intestinal Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Intestinal Medicine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Intestinal Medicine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Pet Intestinal Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pet Intestinal Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pet Intestinal Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Intestinal Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pet Intestinal Medicine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pet Intestinal Medicine market include Boehringer Ingelheim, CAHIC, Ceva, Dechra Veterinary Products, Elanco, Jindun, Norbrook, Ouro Fino Saude and Vetoquinol, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pet Intestinal Medicine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pet Intestinal Medicine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pet Intestinal Medicine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pet Intestinal Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.

Pet Intestinal Medicine Segment by Company

Boehringer Ingelheim

CAHIC

Ceva

Dechra Veterinary Products

Elanco

Jindun

Norbrook

Ouro Fino Saude

Vetoquinol

Virbac

Wuhan chopperlvya

Merck

Zoetis

Pet Intestinal Medicine Segment by Type

Powder

Liquid

Pet Intestinal Medicine Segment by Application

Reptile

Cat

Dog

Other

Pet Intestinal Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pet Intestinal Medicine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pet Intestinal Medicine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pet Intestinal Medicine significant trends, drivers, influence factors in global and regions.

6. To analyze Pet Intestinal Medicine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Intestinal Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Intestinal Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Intestinal Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pet Intestinal Medicine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pet Intestinal Medicine industry.

Chapter 3: Detailed analysis of Pet Intestinal Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pet Intestinal Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pet Intestinal Medicine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pet Intestinal Medicine Industry Trends Table 2. Pet Intestinal Medicine Industry Drivers Table 3. Pet Intestinal Medicine Industry Opportunities and Challenges Table 4. Pet Intestinal Medicine Industry Restraints Table 5. Global Pet Intestinal Medicine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pet Intestinal Medicine Revenue Share by Company (2021-2026) Table 7. Global Pet Intestinal Medicine Sales Volume by Company (k units) & (2021-2026) Table 8. Global Pet Intestinal Medicine Sales Volume Share by Company (2021-2026) Table 9. Global Pet Intestinal Medicine Average Price (US$/unit) of Company (2021-2026) Table 10. Global Pet Intestinal Medicine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pet Intestinal Medicine Key Company Manufacturing Base & Headquarters Table 12. Global Pet Intestinal Medicine Company, Product Type & Application Table 13. Global Pet Intestinal Medicine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pet Intestinal Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Powder Table 18. Significant Companies of Liquid Table 19. Global Pet Intestinal Medicine Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Pet Intestinal Medicine Sales Volume by Type (2021-2026) & (k units) Table 21. Global Pet Intestinal Medicine Sales Volume by Type (2027-2032) & (k units) Table 22. Global Pet Intestinal Medicine Sales Volume Share by Type (2021-2026) Table 23. Global Pet Intestinal Medicine Sales Volume Share by Type (2027-2032) Table 24. Global Pet Intestinal Medicine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pet Intestinal Medicine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Pet Intestinal Medicine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Pet Intestinal Medicine Sales Value Share by Type (2021-2026) Table 28. Global Pet Intestinal Medicine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Reptile Table 30. Significant Companies of Cat Table 31. Significant Companies of Dog Table 32. Significant Companies of Other Table 33. Global Pet Intestinal Medicine Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Pet Intestinal Medicine Sales Volume by Application (2021-2026) & (k units) Table 35. Global Pet Intestinal Medicine Sales Volume by Application (2027-2032) & (k units) Table 36. Global Pet Intestinal Medicine Sales Volume Share by Application (2021-2026) Table 37. Global Pet Intestinal Medicine Sales Volume Share by Application (2027-2032) Table 38. Global Pet Intestinal Medicine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Pet Intestinal Medicine Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Pet Intestinal Medicine Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Pet Intestinal Medicine Sales Value Share by Application (2021-2026) Table 42. Global Pet Intestinal Medicine Sales Value Share by Application (2027-2032) Table 43. Global Pet Intestinal Medicine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Pet Intestinal Medicine Sales by Region (2021-2026) & (k units) Table 45. Global Pet Intestinal Medicine Sales Market Share by Region (2021-2026) Table 46. Global Pet Intestinal Medicine Sales by Region (2027-2032) & (k units) Table 47. Global Pet Intestinal Medicine Sales Market Share by Region (2027-2032) Table 48. Global Pet Intestinal Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Pet Intestinal Medicine Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Pet Intestinal Medicine Sales Value Share by Region (2021-2026) Table 51. Global Pet Intestinal Medicine Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Pet Intestinal Medicine Sales Value Share by Region (2027-2032) Table 53. Global Pet Intestinal Medicine Market Average Price (US$/unit) by Region (2021-2026) Table 54. Global Pet Intestinal Medicine Market Average Price (US$/unit) by Region (2027-2032) Table 55. Global Pet Intestinal Medicine Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Pet Intestinal Medicine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Pet Intestinal Medicine Sales by Country (2021-2026) & (k units) Table 58. Global Pet Intestinal Medicine Sales Market Share by Country (2021-2026) Table 59. Global Pet Intestinal Medicine Sales by Country (2027-2032) & (k units) Table 60. Global Pet Intestinal Medicine Sales Market Share by Country (2027-2032) Table 61. Global Pet Intestinal Medicine Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Pet Intestinal Medicine Sales Value Market Share by Country (2021-2026) Table 63. Global Pet Intestinal Medicine Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Pet Intestinal Medicine Sales Value Market Share by Country (2027-2032) Table 65. Boehringer Ingelheim Company Information Table 66. Boehringer Ingelheim Business Overview Table 67. Boehringer Ingelheim Pet Intestinal Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Boehringer Ingelheim Pet Intestinal Medicine Product Portfolio Table 69. Boehringer Ingelheim Recent Development Table 70. CAHIC Company Information Table 71. CAHIC Business Overview Table 72. CAHIC Pet Intestinal Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. CAHIC Pet Intestinal Medicine Product Portfolio Table 74. CAHIC Recent Development Table 75. Ceva Company Information Table 76. Ceva Business Overview Table 77. Ceva Pet Intestinal Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Ceva Pet Intestinal Medicine Product Portfolio Table 79. Ceva Recent Development Table 80. Dechra Veterinary Products Company Information Table 81. Dechra Veterinary Products Business Overview Table 82. Dechra Veterinary Products Pet Intestinal Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Dechra Veterinary Products Pet Intestinal Medicine Product Portfolio Table 84. Dechra Veterinary Products Recent Development Table 85. Elanco Company Information Table 86. Elanco Business Overview Table 87. Elanco Pet Intestinal Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Elanco Pet Intestinal Medicine Product Portfolio Table 89. Elanco Recent Development Table 90. Jindun Company Information Table 91. Jindun Business Overview Table 92. Jindun Pet Intestinal Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Jindun Pet Intestinal Medicine Product Portfolio Table 94. Jindun Recent Development Table 95. Norbrook Company Information Table 96. Norbrook Business Overview Table 97. Norbrook Pet Intestinal Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Norbrook Pet Intestinal Medicine Product Portfolio Table 99. Norbrook Recent Development Table 100. Ouro Fino Saude Company Information Table 101. Ouro Fino Saude Business Overview Table 102. Ouro Fino Saude Pet Intestinal Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Ouro Fino Saude Pet Intestinal Medicine Product Portfolio Table 104. Ouro Fino Saude Recent Development Table 105. Vetoquinol Company Information Table 106. Vetoquinol Business Overview Table 107. Vetoquinol Pet Intestinal Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Vetoquinol Pet Intestinal Medicine Product Portfolio Table 109. Vetoquinol Recent Development Table 110. Virbac Company Information Table 111. Virbac Business Overview Table 112. Virbac Pet Intestinal Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Virbac Pet Intestinal Medicine Product Portfolio Table 114. Virbac Recent Development Table 115. Wuhan chopperlvya Company Information Table 116. Wuhan chopperlvya Business Overview Table 117. Wuhan chopperlvya Pet Intestinal Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. Wuhan chopperlvya Pet Intestinal Medicine Product Portfolio Table 119. Wuhan chopperlvya Recent Development Table 120. Merck Company Information Table 121. Merck Business Overview Table 122. Merck Pet Intestinal Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. Merck Pet Intestinal Medicine Product Portfolio Table 124. Merck Recent Development Table 125. Zoetis Company Information Table 126. Zoetis Business Overview Table 127. Zoetis Pet Intestinal Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 128. Zoetis Pet Intestinal Medicine Product Portfolio Table 129. Zoetis Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Pet Intestinal Medicine Distributors List Table 133. Pet Intestinal Medicine Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Pet Intestinal Medicine Product Image Figure 2. Global Pet Intestinal Medicine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Intestinal Medicine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pet Intestinal Medicine Sales (2021-2032) & (k units) Figure 5. Global Pet Intestinal Medicine Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Pet Intestinal Medicine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Powder Image Figure 10. Liquid Image Figure 11. Global Pet Intestinal Medicine Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Pet Intestinal Medicine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Pet Intestinal Medicine Sales Volume Share by Type (2021-2032) Figure 14. Global Pet Intestinal Medicine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Pet Intestinal Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Pet Intestinal Medicine Sales Value Share by Type (2021-2032) Figure 17. Reptile Image Figure 18. Cat Image Figure 19. Dog Image Figure 20. Other Image Figure 21. Global Pet Intestinal Medicine Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Pet Intestinal Medicine Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Pet Intestinal Medicine Sales Volume Share by Application (2021-2032) Figure 24. Global Pet Intestinal Medicine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Pet Intestinal Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Pet Intestinal Medicine Sales Value Share by Application (2021-2032) Figure 27. Global Pet Intestinal Medicine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Pet Intestinal Medicine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Pet Intestinal Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Pet Intestinal Medicine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Pet Intestinal Medicine Sales Value (2021-2032) & (US$ Million) Figure 32. North America Pet Intestinal Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Pet Intestinal Medicine Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Pet Intestinal Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Pet Intestinal Medicine Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Pet Intestinal Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Pet Intestinal Medicine Sales Value (2021-2032) & (US$ Million) Figure 38. South America Pet Intestinal Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Pet Intestinal Medicine Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Pet Intestinal Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Pet Intestinal Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Pet Intestinal Medicine Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Pet Intestinal Medicine Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Liquid
Applications
  • Reptile
  • Cat
  • Dog
  • Other
Companies covered
  • Boehringer Ingelheim
  • CAHIC
  • Ceva
  • Dechra Veterinary Products
  • Elanco
  • Jindun
  • Norbrook
  • Ouro Fino Saude
  • Vetoquinol
  • Virbac
  • Wuhan chopperlvya
  • Merck
  • Zoetis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pet Intestinal Medicine Sales Value (2021-2032)
  4. 1.2.2 Global Pet Intestinal Medicine Sales Volume (2021-2032)
  5. 1.2.3 Global Pet Intestinal Medicine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pet Intestinal Medicine Market Dynamics
  1. 2.1 Pet Intestinal Medicine Industry Trends
  2. 2.2 Pet Intestinal Medicine Industry Drivers
  3. 2.3 Pet Intestinal Medicine Industry Opportunities and Challenges
  4. 2.4 Pet Intestinal Medicine Industry Restraints
3 Pet Intestinal Medicine Market by Company
  1. 3.1 Global Pet Intestinal Medicine Company Revenue Ranking in 2025
  2. 3.2 Global Pet Intestinal Medicine Revenue by Company (2021-2026)
  3. 3.3 Global Pet Intestinal Medicine Sales Volume by Company (2021-2026)
  4. 3.4 Global Pet Intestinal Medicine Average Price by Company (2021-2026)
  5. 3.5 Global Pet Intestinal Medicine Company Ranking (2024-2026)
  6. 3.6 Global Pet Intestinal Medicine Company Manufacturing Base and Headquarters
  7. 3.7 Global Pet Intestinal Medicine Company Product Type and Application
  8. 3.8 Global Pet Intestinal Medicine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pet Intestinal Medicine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pet Intestinal Medicine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pet Intestinal Medicine Market by Type
  1. 4.1 Pet Intestinal Medicine Type Introduction
  2. 4.1.1 Powder
  3. 4.1.2 Liquid
  4. 4.2 Global Pet Intestinal Medicine Sales Volume by Type
  5. 4.2.1 Global Pet Intestinal Medicine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pet Intestinal Medicine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Pet Intestinal Medicine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Pet Intestinal Medicine Sales Value by Type
  9. 4.3.1 Global Pet Intestinal Medicine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pet Intestinal Medicine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Pet Intestinal Medicine Sales Value Share by Type (2021-2032)
5 Pet Intestinal Medicine Market by Application
  1. 5.1 Pet Intestinal Medicine Application Introduction
  2. 5.1.1 Reptile
  3. 5.1.2 Cat
  4. 5.1.3 Dog
  5. 5.1.4 Other
  6. 5.2 Global Pet Intestinal Medicine Sales Volume by Application
  7. 5.2.1 Global Pet Intestinal Medicine Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pet Intestinal Medicine Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Pet Intestinal Medicine Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Pet Intestinal Medicine Sales Value by Application
  11. 5.3.1 Global Pet Intestinal Medicine Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Pet Intestinal Medicine Sales Value by Application (2021-2032)
  13. 5.3.3 Global Pet Intestinal Medicine Sales Value Share by Application (2021-2032)
6 Pet Intestinal Medicine Regional Sales and Value Analysis
  1. 6.1 Global Pet Intestinal Medicine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pet Intestinal Medicine Sales by Region (2021-2032)
  3. 6.2.1 Global Pet Intestinal Medicine Sales by Region: 2021-2026
  4. 6.2.2 Global Pet Intestinal Medicine Sales by Region (2027-2032)
  5. 6.3 Global Pet Intestinal Medicine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pet Intestinal Medicine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pet Intestinal Medicine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pet Intestinal Medicine Sales Value by Region (2027-2032)
  9. 6.5 Global Pet Intestinal Medicine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pet Intestinal Medicine Sales Value (2021-2032)
  12. 6.6.2 North America Pet Intestinal Medicine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pet Intestinal Medicine Sales Value (2021-2032)
  15. 6.7.2 Europe Pet Intestinal Medicine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pet Intestinal Medicine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pet Intestinal Medicine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pet Intestinal Medicine Sales Value (2021-2032)
  21. 6.9.2 South America Pet Intestinal Medicine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pet Intestinal Medicine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pet Intestinal Medicine Sales Value Share by Country, 2025 VS 2032
7 Pet Intestinal Medicine Country-level Sales and Value Analysis
  1. 7.1 Global Pet Intestinal Medicine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pet Intestinal Medicine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pet Intestinal Medicine Sales by Country (2021-2032)
  4. 7.3.1 Global Pet Intestinal Medicine Sales by Country (2021-2026)
  5. 7.3.2 Global Pet Intestinal Medicine Sales by Country (2027-2032)
  6. 7.4 Global Pet Intestinal Medicine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pet Intestinal Medicine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pet Intestinal Medicine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pet Intestinal Medicine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pet Intestinal Medicine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pet Intestinal Medicine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim
  2. 8.1.1 Boehringer Ingelheim Company Information
  3. 8.1.2 Boehringer Ingelheim Business Overview
  4. 8.1.3 Boehringer Ingelheim Pet Intestinal Medicine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim Pet Intestinal Medicine Product Portfolio
  6. 8.1.5 Boehringer Ingelheim Recent Developments
  7. 8.2 CAHIC
  8. 8.2.1 CAHIC Company Information
  9. 8.2.2 CAHIC Business Overview
  10. 8.2.3 CAHIC Pet Intestinal Medicine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 CAHIC Pet Intestinal Medicine Product Portfolio
  12. 8.2.5 CAHIC Recent Developments
  13. 8.3 Ceva
  14. 8.3.1 Ceva Company Information
  15. 8.3.2 Ceva Business Overview
  16. 8.3.3 Ceva Pet Intestinal Medicine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Ceva Pet Intestinal Medicine Product Portfolio
  18. 8.3.5 Ceva Recent Developments
  19. 8.4 Dechra Veterinary Products
  20. 8.4.1 Dechra Veterinary Products Company Information
  21. 8.4.2 Dechra Veterinary Products Business Overview
  22. 8.4.3 Dechra Veterinary Products Pet Intestinal Medicine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Dechra Veterinary Products Pet Intestinal Medicine Product Portfolio
  24. 8.4.5 Dechra Veterinary Products Recent Developments
  25. 8.5 Elanco
  26. 8.5.1 Elanco Company Information
  27. 8.5.2 Elanco Business Overview
  28. 8.5.3 Elanco Pet Intestinal Medicine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Elanco Pet Intestinal Medicine Product Portfolio
  30. 8.5.5 Elanco Recent Developments
  31. 8.6 Jindun
  32. 8.6.1 Jindun Company Information
  33. 8.6.2 Jindun Business Overview
  34. 8.6.3 Jindun Pet Intestinal Medicine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jindun Pet Intestinal Medicine Product Portfolio
  36. 8.6.5 Jindun Recent Developments
  37. 8.7 Norbrook
  38. 8.7.1 Norbrook Company Information
  39. 8.7.2 Norbrook Business Overview
  40. 8.7.3 Norbrook Pet Intestinal Medicine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Norbrook Pet Intestinal Medicine Product Portfolio
  42. 8.7.5 Norbrook Recent Developments
  43. 8.8 Ouro Fino Saude
  44. 8.8.1 Ouro Fino Saude Company Information
  45. 8.8.2 Ouro Fino Saude Business Overview
  46. 8.8.3 Ouro Fino Saude Pet Intestinal Medicine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Ouro Fino Saude Pet Intestinal Medicine Product Portfolio
  48. 8.8.5 Ouro Fino Saude Recent Developments
  49. 8.9 Vetoquinol
  50. 8.9.1 Vetoquinol Company Information
  51. 8.9.2 Vetoquinol Business Overview
  52. 8.9.3 Vetoquinol Pet Intestinal Medicine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Vetoquinol Pet Intestinal Medicine Product Portfolio
  54. 8.9.5 Vetoquinol Recent Developments
  55. 8.10 Virbac
  56. 8.10.1 Virbac Company Information
  57. 8.10.2 Virbac Business Overview
  58. 8.10.3 Virbac Pet Intestinal Medicine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Virbac Pet Intestinal Medicine Product Portfolio
  60. 8.10.5 Virbac Recent Developments
  61. 8.11 Wuhan chopperlvya
  62. 8.11.1 Wuhan chopperlvya Company Information
  63. 8.11.2 Wuhan chopperlvya Business Overview
  64. 8.11.3 Wuhan chopperlvya Pet Intestinal Medicine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Wuhan chopperlvya Pet Intestinal Medicine Product Portfolio
  66. 8.11.5 Wuhan chopperlvya Recent Developments
  67. 8.12 Merck
  68. 8.12.1 Merck Company Information
  69. 8.12.2 Merck Business Overview
  70. 8.12.3 Merck Pet Intestinal Medicine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Merck Pet Intestinal Medicine Product Portfolio
  72. 8.12.5 Merck Recent Developments
  73. 8.13 Zoetis
  74. 8.13.1 Zoetis Company Information
  75. 8.13.2 Zoetis Business Overview
  76. 8.13.3 Zoetis Pet Intestinal Medicine Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Zoetis Pet Intestinal Medicine Product Portfolio
  78. 8.13.5 Zoetis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pet Intestinal Medicine Value Chain Analysis
  2. 9.1.1 Pet Intestinal Medicine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pet Intestinal Medicine Sales Mode & Process
  6. 9.2 Pet Intestinal Medicine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pet Intestinal Medicine Distributors
  9. 9.2.3 Pet Intestinal Medicine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst